Skip to main content
PMC home page
Netherlands Heart Journal logoLink to Netherlands Heart Journal
. 2004 Dec;12(12):548–554.

Heart failure: chapter 8. Treatment of end-stage heart failure

N de Jonge, PJMJ Vantrimpont
PMCID: PMC2497214  PMID: 25696289

Full text

PDF
548

Images in this article

553Figure 3
on p.553

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews R., Charlesworth A., Evans A., Cowley A. J. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. Eur Heart J. 1997 May;18(5):852–857. doi: 10.1093/oxfordjournals.eurheartj.a015351. [DOI] [PubMed] [Google Scholar]
  2. Colucci W. S., Elkayam U., Horton D. P., Abraham W. T., Bourge R. C., Johnson A. D., Wagoner L. E., Givertz M. M., Liang C. S., Neibaur M. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 2000 Jul 27;343(4):246–253. doi: 10.1056/NEJM200007273430403. [DOI] [PubMed] [Google Scholar]
  3. Delea T. E., Vera-Llonch M., Richner R. E., Fowler M. B., Oster G. Cost effectiveness of carvedilol for heart failure. Am J Cardiol. 1999 Mar 15;83(6):890–896. doi: 10.1016/s0002-9149(98)01066-2. [DOI] [PubMed] [Google Scholar]
  4. Dikshit K., Vyden J. K., Forrester J. S., Chatterjee K., Prakash R., Swan H. J. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973 May 24;288(21):1087–1090. doi: 10.1056/NEJM197305242882102. [DOI] [PubMed] [Google Scholar]
  5. Dormans T. P., van Meyel J. J., Gerlag P. G., Tan Y., Russel F. G., Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996 Aug;28(2):376–382. doi: 10.1016/0735-1097(96)00161-1. [DOI] [PubMed] [Google Scholar]
  6. Drazner M. H., Hamilton M. A., Fonarow G., Creaser J., Flavell C., Stevenson L. W. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999 Nov;18(11):1126–1132. doi: 10.1016/s1053-2498(99)00070-4. [DOI] [PubMed] [Google Scholar]
  7. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991 Aug 1;325(5):293–302. doi: 10.1056/NEJM199108013250501. [DOI] [PubMed] [Google Scholar]
  8. Gao S. Z., Alderman E. L., Schroeder J. S., Silverman J. F., Hunt S. A. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988 Aug;12(2):334–340. doi: 10.1016/0735-1097(88)90402-0. [DOI] [PubMed] [Google Scholar]
  9. Gerlag P. G., van Meijel J. J. High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med. 1988 Feb;148(2):286–291. [PubMed] [Google Scholar]
  10. Ghali J. K., Kadakia S., Cooper R., Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med. 1988 Sep;148(9):2013–2016. [PubMed] [Google Scholar]
  11. Gheorghiade Mihai, Colucci Wilson S., Swedberg Karl. Beta-blockers in chronic heart failure. Circulation. 2003 Apr 1;107(12):1570–1575. doi: 10.1161/01.CIR.0000065187.80707.18. [DOI] [PubMed] [Google Scholar]
  12. Grady K. L., Dracup K., Kennedy G., Moser D. K., Piano M., Stevenson L. W., Young J. B. Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation. 2000 Nov 7;102(19):2443–2456. doi: 10.1161/01.cir.102.19.2443. [DOI] [PubMed] [Google Scholar]
  13. Grinstead W. C., Francis M. J., Marks G. F., Tawa C. B., Zoghbi W. A., Young J. B. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol. 1994 May 1;73(12):881–886. doi: 10.1016/0002-9149(94)90815-x. [DOI] [PubMed] [Google Scholar]
  14. Hampton J. R., van Veldhuisen D. J., Kleber F. X., Cowley A. J., Ardia A., Block P., Cortina A., Cserhalmi L., Follath F., Jensen G. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet. 1997 Apr 5;349(9057):971–977. doi: 10.1016/s0140-6736(96)10488-8. [DOI] [PubMed] [Google Scholar]
  15. Hunt S. A., Frazier O. H. Mechanical circulatory support and cardiac transplantation. Circulation. 1998 May 26;97(20):2079–2090. doi: 10.1161/01.cir.97.20.2079. [DOI] [PubMed] [Google Scholar]
  16. Kao A. C., Van Trigt P., 3rd, Shaeffer-McCall G. S., Shaw J. P., Kuzil B. B., Page R. D., Higginbotham M. B. Allograft diastolic dysfunction and chronotropic incompetence limit cardiac output response to exercise two to six years after heart transplantation. J Heart Lung Transplant. 1995 Jan-Feb;14(1 Pt 1):11–22. [PubMed] [Google Scholar]
  17. Keating Gillian M., Goa Karen L. Nesiritide: a review of its use in acute decompensated heart failure. Drugs. 2003;63(1):47–70. doi: 10.2165/00003495-200363010-00004. [DOI] [PubMed] [Google Scholar]
  18. Kuchar D. L., O'Rourke M. F. High dose furosemide in refractory cardiac failure. Eur Heart J. 1985 Nov;6(11):954–958. doi: 10.1093/oxfordjournals.eurheartj.a061793. [DOI] [PubMed] [Google Scholar]
  19. Levin H. R., Weisfeldt M. L. Deep thoughts on tin men. Fact, fallacy, and future of mechanical circulatory support. Circulation. 1997 May 20;95(10):2340–2343. doi: 10.1161/01.cir.95.10.2340. [DOI] [PubMed] [Google Scholar]
  20. Nohria Anju, Lewis Eldrin, Stevenson Lynne Warner. Medical management of advanced heart failure. JAMA. 2002 Feb 6;287(5):628–640. doi: 10.1001/jama.287.5.628. [DOI] [PubMed] [Google Scholar]
  21. O'Connor C. M., Gattis W. A., Uretsky B. F., Adams K. F., Jr, McNulty S. E., Grossman S. H., McKenna W. J., Zannad F., Swedberg K., Gheorghiade M. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999 Jul;138(1 Pt 1):78–86. doi: 10.1016/s0002-8703(99)70250-4. [DOI] [PubMed] [Google Scholar]
  22. Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334(21):1349–1355. doi: 10.1056/NEJM199605233342101. [DOI] [PubMed] [Google Scholar]
  23. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  24. Packer M., Coats A. J., Fowler M. B., Katus H. A., Krum H., Mohacsi P., Rouleau J. L., Tendera M., Castaigne A., Roecker E. B. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001 May 31;344(22):1651–1658. doi: 10.1056/NEJM200105313442201. [DOI] [PubMed] [Google Scholar]
  25. Packer Milton, Fowler Michael B., Roecker Ellen B., Coats Andrew J. S., Katus Hugo A., Krum Henry, Mohacsi Paul, Rouleau Jean L., Tendera Michal, Staiger Christoph. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002 Oct 22;106(17):2194–2199. doi: 10.1161/01.cir.0000035653.72855.bf. [DOI] [PubMed] [Google Scholar]
  26. Richardson A., Bayliss J., Scriven A. J., Parameshwar J., Poole-Wilson P. A., Sutton G. C. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet. 1987 Sep 26;2(8561):709–711. doi: 10.1016/s0140-6736(87)91074-9. [DOI] [PubMed] [Google Scholar]
  27. Rose E. A., Gelijns A. C., Moskowitz A. J., Heitjan D. F., Stevenson L. W., Dembitsky W., Long J. W., Ascheim D. D., Tierney A. R., Levitan R. G. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001 Nov 15;345(20):1435–1443. doi: 10.1056/NEJMoa012175. [DOI] [PubMed] [Google Scholar]
  28. Shipley J. B., Tolman D., Hastillo A., Hess M. L. Milrinone: basic and clinical pharmacology and acute and chronic management. Am J Med Sci. 1996 Jun;311(6):286–291. doi: 10.1097/00000441-199606000-00011. [DOI] [PubMed] [Google Scholar]
  29. Steimle A. E., Stevenson L. W., Fonarow G. C., Hamilton M. A., Moriguchi J. D. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol. 1994 Mar 1;23(3):553–559. doi: 10.1016/0735-1097(94)90735-8. [DOI] [PubMed] [Google Scholar]
  30. Stevenson L. W., Massie B. M., Francis G. S. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J. 1998 Jun;135(6 Pt 2 SU):S293–S309. doi: 10.1016/s0002-8703(98)70257-1. [DOI] [PubMed] [Google Scholar]
  31. Taylor David O., Edwards Leah B., Boucek Mark M., Trulock Elbert P., Keck Berkeley M., Hertz Marshall I. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant. 2004 Jul;23(7):796–803. doi: 10.1016/j.healun.2004.05.004. [DOI] [PubMed] [Google Scholar]
  32. Tsevat J., Duke D., Goldman L., Pfeffer M. A., Lamas G. A., Soukup J. R., Kuntz K. M., Lee T. H. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol. 1995 Oct;26(4):914–919. doi: 10.1016/0735-1097(95)00284-1. [DOI] [PubMed] [Google Scholar]
  33. Walma E. P., Hoes A. W., van Dooren C., Prins A., van der Does E. Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. BMJ. 1997 Aug 23;315(7106):464–468. doi: 10.1136/bmj.315.7106.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zaroff Jonathan G., Rosengard Bruce R., Armstrong William F., Babcock Wayne D., D'Alessandro Anthony, Dec G. William, Edwards Niloo M., Higgins Robert S., Jeevanandum Valluvan, Kauffman Myron. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002 Aug 13;106(7):836–841. doi: 10.1161/01.cir.0000025587.40373.75. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES